Odonate Therapeutics, Inc. – OTC:ODTC

Add to watchlist

$1.8

-17098.2

-99.99%

Market closed

Open in 3 days

+500.11%

month

+418.18%

quarter

+994086.05%

year

Market Cap	69.28M
Enterprise value	N/A

P/E	-0.67
EV/Sales	N/A
EV/EBITDA	0.21
Price/Sales	N/A
Price/Book	0.95
PEG ratio	-0.12
EPS	15277.97

Revenue	N/A
EBITDA	-17.78M
Income	-2.47M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Odonate Therapeutics, Inc. (OTC:ODTC): Profit margin
Jun 2021	0	-22.48M
Sep 2021	0	-23.93M
Sep 2022	0	39.19M
Dec 2022	0	4.75M

Odonate Therapeutics, Inc. (OTC:ODTC): Debt to assets
Dec 2020	167886000	31.74M	18.91%
Mar 2021	142879000	37.57M	26.3%
Jun 2021	118573000	33.94M	28.63%
Sep 2021	105773000	34.40M	32.52%

Odonate Therapeutics, Inc. (OTC:ODTC): Cash Flow
Mar 2021	-24.90M	-21K	825K
Jun 2021	-23.02M	-5K	0
Sep 2021	-15.09M	0	0
Dec 2022	5.47M	-37.39M	0

Odonate Therapeutics alternative data

Odonate Therapeutics
Employees

Odonate Therapeutics, Inc. (OTC:ODTC): Employee count
Aug 2023	137
Sep 2023	137
Oct 2023	137
Nov 2023	137
Dec 2023	137
Jan 2024	137
Feb 2024	137
Mar 2024	137
Apr 2024	137
May 2024	137
Jun 2024	137
Jul 2024	137

Odonate Therapeutics
Hedge Funds Holdings Q1 2022

14.26% -49.66%

of ODTC is owned by hedge funds

6 -38

hedge funds hold ODTC stock

5.40M -18.83M

shares is hold by hedge funds

ODTC hedge funds holdings changes

Frequently Asked Questions (FAQ)

What's the price of Odonate Therapeutics stock today?

One share of Odonate Therapeutics stock can currently be purchased for approximately $1.8.
When is Odonate Therapeutics's next earnings date?

Unfortunately, Odonate Therapeutics's (ODTC) next earnings date is currently unknown.
Does Odonate Therapeutics pay dividends?

No, Odonate Therapeutics does not pay dividends.
How much money does Odonate Therapeutics make?

Odonate Therapeutics has a market capitalization of 69.28M.
What is Odonate Therapeutics's stock symbol?

Odonate Therapeutics, Inc. is traded on the OTC under the ticker symbol "ODTC".
What is Odonate Therapeutics's primary industry?

Company operates in the Financial Services sector and Shell Companies industry.
How do i buy shares of Odonate Therapeutics?

Shares of Odonate Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Odonate Therapeutics have?

As Jul 2024, Odonate Therapeutics employs 137 workers.
When Odonate Therapeutics went public?

Odonate Therapeutics, Inc. is publicly traded company for more then 7 years since IPO on 7 Dec 2017.
What is Odonate Therapeutics's official website?

The official website for Odonate Therapeutics is odonate.com.
Where are Odonate Therapeutics's headquarters?

Odonate Therapeutics is headquartered at 3 East 28th Street, New York, NY.
How can i contact Odonate Therapeutics?

Odonate Therapeutics's mailing address is 3 East 28th Street, New York, NY and company can be reached via phone at +33 22060935.

Odonate Therapeutics, Inc.

odonate.com

Exchange:

OTC

Full time employees:

137

Industry:

Shell Companies

Sector:

Financial Services

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

+33 22060935

3 East 28th Street
New York, NY 10016

CIK: 0001717452
ISIN: US6760791060
CUSIP: 676079106